DNA and Gene Chip Market Analysis Report By Product (Consumables, Instrumentation), By Application (Cancer Diagnosis & Treatment, Drug Delivery, Genomics), By End Use, And Segment Forecasts, 2018 - 2025
This report can be delivered to the clients within 24 Business Hours
The global DNA & gene chip market size is expected to reach USD 10.7 billion by 2025, according to a new report by Grand View Research, Inc., at an 11.4% CAGR during the forecast period. DNA and gene chips have gained much success in providing high throughput capabilities for comprehensive genome studies to enhance disease knowledge and target them. This technology has emerged as a valuable and promising solution across various aspects of disease management. These factors have been driving the market.
Conventional means of gene analysis allow investigation of relatively small amounts of genes at a time, which further emphasizes on the uptake of DNA microarray technology. DNA microarray technology allows concurrent analysis of very large numbers of nucleic acid fragments in a single experiment.
Continuous development of new tools to support and enhance reliability of DNA microarray technology is likely to drive this market at a significant pace in the foreseeable future. Furthermore, healthcare entities are engaged in exploiting novel solutions for enhancing and combining data generated from gene chip with data generated from high throughput technologies. Mutually beneficial partnerships between microarray developers and pharmaceutical/biopharmaceutical companies for acceleration of genomic and biomedical research activities is anticipated to spur market growth in the coming years.
Further key findings from the report suggest:
The global DNA & gene chip market size is expected to reach USD 10.7 billion by 2025, according to a new report by Grand View Research, Inc., at an 11.4% CAGR during the forecast period. DNA and gene chips have gained much success in providing high throughput capabilities for comprehensive genome studies to enhance disease knowledge and target them. This technology has emerged as a valuable and promising solution across various aspects of disease management. These factors have been driving the market.
Conventional means of gene analysis allow investigation of relatively small amounts of genes at a time, which further emphasizes on the uptake of DNA microarray technology. DNA microarray technology allows concurrent analysis of very large numbers of nucleic acid fragments in a single experiment.
Continuous development of new tools to support and enhance reliability of DNA microarray technology is likely to drive this market at a significant pace in the foreseeable future. Furthermore, healthcare entities are engaged in exploiting novel solutions for enhancing and combining data generated from gene chip with data generated from high throughput technologies. Mutually beneficial partnerships between microarray developers and pharmaceutical/biopharmaceutical companies for acceleration of genomic and biomedical research activities is anticipated to spur market growth in the coming years.
Further key findings from the report suggest:
- Based on product, consumables dominated the market with the largest share. This is due to presence of large number of entities engaged in providing reagents and kits associated with the use of DNA chips
- The cancer treatment and diagnosis segment accounts for a significant share in the market owing to rising inclination toward development of companion diagnostics and growing usage of DNA microarrays in cancer diagnosis and treatment
- Implementation of gene chip for drug discovery is also expected to increase in the coming years owing to growing demand for personalized medicine
- By end use, academic/government research institutes accounted for the largest share in 2017. Ongoing research projects on gene expression analysis in these institutes have attributed for the estimated share
- In terms of region, North America dominated the market with by revenue. High penetration of major revenue generating companies in U.S. has contributed to its leading share
- Asia Pacific is projected to witness the fastest year-on-year growth owing to rising healthcare spending in developing economies and increase in R&D investment
- Some of the prominent market participants are Agilent Technologies; Thermo Fisher Scientific, Incorporated (Affymetrix, Inc.); Illumina, Inc.; Macrogen Inc.; and Arrayit Corporation. These players are engaged in mutual partnerships with research communities and other diagnostic firms for use of gene chips for targeting disease prognosis.
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Information Procurement
1.2 Data Analysis
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 DNA & GENE CHIP MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Growing demand for personalized cancer treatment
3.1.1.2 Less complexity of microarrays as compared with other sequencing technologies in terms sample preparation and data interpretation
3.1.1.3 Growth in genomics r & d
3.1.2 Market Restraint Analysis
3.1.2.1 Concurrent decline in sequencing price
3.1.2.2 Regulatory changes and technological advancements in NGS
3.2 Penetration & Growth Prospect Mapping for Application, 2017
3.3 DNA & Gene Chip-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
CHAPTER 4 DNA & GENE CHIP MARKET CATEGORIZATION: APPLICATION ESTIMATES & TREND ANALYSIS
4.1 Global DNA & Gene Chip Market: Application Movement Analysis
4.2 Cancer Diagnosis & Treatment
4.2.1 Global cancer diagnosis & treatment market, 2014 - 2025 (USD Million)
4.3 Gene Expression
4.3.1 Global gene expression market, 2014 - 2025 (USD Million)
4.4 Genotyping
4.4.1 Global SNP genotyping market, 2014 - 2025 (USD Million)
4.5 Genomics
4.5.1 Global genomics market, 2014 - 2025 (USD Million)
4.6 Drug Discovery
4.6.1 Global drug discovery market, 2014 - 2025 (USD Million)
4.7 Agricultural Biotechnology
4.7.1 Global agricultural biotechnology market, 2014 - 2025 (USD Million)
4.8 Others
4.8.1 Global other application market, 2014 - 2025 (USD Million)
CHAPTER 5 DNA & GENE CHIP MARKET CATEGORIZATION: PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Global DNA & Gene Chip Market: Product Movement Analysis
5.2 Consumables
5.2.1 Global consumables market, 2014 - 2025 (USD Million)
5.3 Instrumentation
5.3.1 Global instrumentation market, 2014 - 2025 (USD Million)
CHAPTER 6 DNA & GENE CHIP MARKET CATEGORIZATION: END-USE ESTIMATES & TREND ANALYSIS
6.1 Global DNA & Gene Chip Market: End-use Movement Analysis
6.2 Academic & Government Research Institutes
6.2.1 Global academic & government research institutes market, 2014 - 2025 (USD Million)
6.3 Hospitals & Diagnostics Centers
6.3.1 Global hospitals & diagnostics centers market, 2014 - 2025 (USD Million)
6.4 Biotechnology & Pharmaceutical Companies
6.4.1 Global biotechnology & pharmaceutical companies market, 2014 - 2025 (USD Million)
6.5 Others
6.5.1 Global other end-use market, 2014 - 2025 (USD Million)
CHAPTER 7 DNA & GENE CHIP MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS, BY APPLICATION, TYPE, & END-USE
7.1 DNA & Gene Chip Market Share By Region, 2017 & 2025
7.2 North America
7.2.1 North America DNA & gene chip market, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. DNA & gene chip market, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada DNA & gene chip market, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe DNA & gene chip market, 2014 - 2025 (USD Million)
7.3.2 Germany
7.3.2.1 Germany DNA & gene chip market, 2014 - 2025 (USD Million)
7.3.3 U.K.
7.3.3.1 U.K. DNA & gene chip market, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific DNA & gene chip market, 2014 - 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan DNA & gene chip market, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 China DNA & gene chip market, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America DNA & gene chip market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil DNA & gene chip market, 2014 - 2025 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 MEA DNA & gene chip market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa DNA & gene chip market, 2014 - 2025 (USD Million)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Thermo Fisher Scientific, Inc.
8.3.1.1 Company overview
8.3.1.2 Affymetrix, Inc.
8.3.1.3 Financial performance
8.3.1.3.1 Financial performance
8.3.1.4 Product benchmarking
8.3.1.5 Strategic initiatives
8.3.2 Agilent Technologies
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 Illumina, Inc.
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 Perkin Elmer, Inc.
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Arrayit Corporation
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Macrogen Inc.
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.7 Asper Biotech
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.8 CapitalBio Corporation
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Greiner Bio One International GmbH
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Microarrays Inc.
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 MYcroarray
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.12 Oxford Gene Technology
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic initiatives
8.3.13 TOSHIBA HOKUTO ELECTRONICS CORPORATION
8.3.13.1 Company overview
8.3.13.2 Financial performance
8.3.13.3 Product benchmarking
8.3.14 Savyon Diagnostics
8.3.14.1 Company overview
8.3.14.2 Financial performance
8.3.14.3 Product benchmarking
8.3.15 Applied Micro Arrays
8.3.15.1 Company overview
8.3.15.2 Financial performance
8.3.15.3 Product benchmarking
8.3.15.4 Strategic initiatives
8.3.16 bioM?rieux SA
8.3.16.1 Company overview
8.3.16.2 Financial performance
8.3.16.3 Product benchmarking
8.3.16.4 Strategic initiatives
1.1 Information Procurement
1.2 Data Analysis
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 DNA & GENE CHIP MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Growing demand for personalized cancer treatment
3.1.1.2 Less complexity of microarrays as compared with other sequencing technologies in terms sample preparation and data interpretation
3.1.1.3 Growth in genomics r & d
3.1.2 Market Restraint Analysis
3.1.2.1 Concurrent decline in sequencing price
3.1.2.2 Regulatory changes and technological advancements in NGS
3.2 Penetration & Growth Prospect Mapping for Application, 2017
3.3 DNA & Gene Chip-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
CHAPTER 4 DNA & GENE CHIP MARKET CATEGORIZATION: APPLICATION ESTIMATES & TREND ANALYSIS
4.1 Global DNA & Gene Chip Market: Application Movement Analysis
4.2 Cancer Diagnosis & Treatment
4.2.1 Global cancer diagnosis & treatment market, 2014 - 2025 (USD Million)
4.3 Gene Expression
4.3.1 Global gene expression market, 2014 - 2025 (USD Million)
4.4 Genotyping
4.4.1 Global SNP genotyping market, 2014 - 2025 (USD Million)
4.5 Genomics
4.5.1 Global genomics market, 2014 - 2025 (USD Million)
4.6 Drug Discovery
4.6.1 Global drug discovery market, 2014 - 2025 (USD Million)
4.7 Agricultural Biotechnology
4.7.1 Global agricultural biotechnology market, 2014 - 2025 (USD Million)
4.8 Others
4.8.1 Global other application market, 2014 - 2025 (USD Million)
CHAPTER 5 DNA & GENE CHIP MARKET CATEGORIZATION: PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Global DNA & Gene Chip Market: Product Movement Analysis
5.2 Consumables
5.2.1 Global consumables market, 2014 - 2025 (USD Million)
5.3 Instrumentation
5.3.1 Global instrumentation market, 2014 - 2025 (USD Million)
CHAPTER 6 DNA & GENE CHIP MARKET CATEGORIZATION: END-USE ESTIMATES & TREND ANALYSIS
6.1 Global DNA & Gene Chip Market: End-use Movement Analysis
6.2 Academic & Government Research Institutes
6.2.1 Global academic & government research institutes market, 2014 - 2025 (USD Million)
6.3 Hospitals & Diagnostics Centers
6.3.1 Global hospitals & diagnostics centers market, 2014 - 2025 (USD Million)
6.4 Biotechnology & Pharmaceutical Companies
6.4.1 Global biotechnology & pharmaceutical companies market, 2014 - 2025 (USD Million)
6.5 Others
6.5.1 Global other end-use market, 2014 - 2025 (USD Million)
CHAPTER 7 DNA & GENE CHIP MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS, BY APPLICATION, TYPE, & END-USE
7.1 DNA & Gene Chip Market Share By Region, 2017 & 2025
7.2 North America
7.2.1 North America DNA & gene chip market, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. DNA & gene chip market, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada DNA & gene chip market, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe DNA & gene chip market, 2014 - 2025 (USD Million)
7.3.2 Germany
7.3.2.1 Germany DNA & gene chip market, 2014 - 2025 (USD Million)
7.3.3 U.K.
7.3.3.1 U.K. DNA & gene chip market, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific DNA & gene chip market, 2014 - 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan DNA & gene chip market, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 China DNA & gene chip market, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America DNA & gene chip market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil DNA & gene chip market, 2014 - 2025 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 MEA DNA & gene chip market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa DNA & gene chip market, 2014 - 2025 (USD Million)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Thermo Fisher Scientific, Inc.
8.3.1.1 Company overview
8.3.1.2 Affymetrix, Inc.
8.3.1.3 Financial performance
8.3.1.3.1 Financial performance
8.3.1.4 Product benchmarking
8.3.1.5 Strategic initiatives
8.3.2 Agilent Technologies
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 Illumina, Inc.
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 Perkin Elmer, Inc.
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Arrayit Corporation
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Macrogen Inc.
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.7 Asper Biotech
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.8 CapitalBio Corporation
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Greiner Bio One International GmbH
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Microarrays Inc.
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 MYcroarray
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.12 Oxford Gene Technology
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic initiatives
8.3.13 TOSHIBA HOKUTO ELECTRONICS CORPORATION
8.3.13.1 Company overview
8.3.13.2 Financial performance
8.3.13.3 Product benchmarking
8.3.14 Savyon Diagnostics
8.3.14.1 Company overview
8.3.14.2 Financial performance
8.3.14.3 Product benchmarking
8.3.15 Applied Micro Arrays
8.3.15.1 Company overview
8.3.15.2 Financial performance
8.3.15.3 Product benchmarking
8.3.15.4 Strategic initiatives
8.3.16 bioM?rieux SA
8.3.16.1 Company overview
8.3.16.2 Financial performance
8.3.16.3 Product benchmarking
8.3.16.4 Strategic initiatives
LIST OF TABLES
Table 1 Cancer diagnostics: Pipeline analysis
Table 2 Service & technology provider in the North America
Table 3 North America DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 4 North America DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 5 North America DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 6 U.S. DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 7 U.S. DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 8 U.S. DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 9 Canada DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 10 Canada DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 11 Canada DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 12 Europe DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 13 Europe DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 14 Europe DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 15 Germany DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 16 Germany DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 17 Germany DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 18 U.K. DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 19 U.K. DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 20 U.K. DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 21 Asia Pacific DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 22 Asia Pacific DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 23 Asia Pacific DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 24 Japan DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 25 Japan DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 26 Japan DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 27 China DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 28 China DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 29 China DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 30 Latin America DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 31 Latin America DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 32 Latin America DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 33 Brazil DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 34 Brazil DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 35 Brazil DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 36 MEA DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 37 MEA DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 38 MEA DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 39 South Africa DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 40 South Africa DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 41 South Africa DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 1 Cancer diagnostics: Pipeline analysis
Table 2 Service & technology provider in the North America
Table 3 North America DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 4 North America DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 5 North America DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 6 U.S. DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 7 U.S. DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 8 U.S. DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 9 Canada DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 10 Canada DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 11 Canada DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 12 Europe DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 13 Europe DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 14 Europe DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 15 Germany DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 16 Germany DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 17 Germany DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 18 U.K. DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 19 U.K. DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 20 U.K. DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 21 Asia Pacific DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 22 Asia Pacific DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 23 Asia Pacific DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 24 Japan DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 25 Japan DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 26 Japan DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 27 China DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 28 China DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 29 China DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 30 Latin America DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 31 Latin America DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 32 Latin America DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 33 Brazil DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 34 Brazil DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 35 Brazil DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 36 MEA DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 37 MEA DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 38 MEA DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
Table 39 South Africa DNA & gene chip market estimates & forecasts, by application, 2014 - 2025 (USD Million)
Table 40 South Africa DNA & gene chip market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Table 41 South Africa DNA & gene chip market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market summary
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping for Application, 2017
Fig. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Global DNA & gene chip market: Application outlook key takeaways
Fig. 16 Global DNA & gene chip market: Application movement analysis
Fig. 17 Global cancer diagnosis & treatment market, 2014 - 2025 (USD Million)
Fig. 18 Global gene expression market, 2014 - 2025 (USD Million)
Fig. 19 Global SNP genotyping market, 2014 - 2025 (USD Million)
Fig. 20 Global genomics arket, 2014 - 2025 (USD Million)
Fig. 21 Global drug discovery market, 2014 - 2025 (USD Million)
Fig. 22 Global agricultural biotechnology market, 2014 - 2025 (USD Million)
Fig. 23 Global other application market, 2014 - 2025 (USD Million)
Fig. 24 Global DNA & gene chip market: Product outlook key takeaways
Fig. 25 Global DNA & gene chip market: Product movement analysis
Fig. 26 Global consumables market, 2014 - 2025 (USD Million)
Fig. 27 Global instrumentation market, 2014 - 2025 (USD Million)
Fig. 28 Global DNA & gene chip market: End-use outlook key takeaways
Fig. 29 Global DNA & gene chip market: End-use movement analysis
Fig. 30 Global academic & government research institutes market, 2014 - 2025 (USD Million)
Fig. 31 Global hospitals & diagnostics centers market, 2014 - 2025 (USD Million)
Fig. 32 Global biotechnology & pharmaceutical companies market, 2014 - 2025 (USD Million)
Fig. 33 Global other end-use market, 2014 - 2025 (USD Million)
Fig. 34 Regional market place: Key takeaway
Fig. 35 DNA & gene chip regional outlook, 2017 & 2025
Fig. 36 North America DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 37 U.S. DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 38 Canada DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 39 Europe DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 40 Germany DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 41 U.K. DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 42 Asia Pacific DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 43 Japan DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 44 China DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 45 Latin America DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 46 Brazil DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 47 MEA DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 48 South Africa DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 49 Strategy framework
Fig. 50 Participant categorization
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market summary
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping for Application, 2017
Fig. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Global DNA & gene chip market: Application outlook key takeaways
Fig. 16 Global DNA & gene chip market: Application movement analysis
Fig. 17 Global cancer diagnosis & treatment market, 2014 - 2025 (USD Million)
Fig. 18 Global gene expression market, 2014 - 2025 (USD Million)
Fig. 19 Global SNP genotyping market, 2014 - 2025 (USD Million)
Fig. 20 Global genomics arket, 2014 - 2025 (USD Million)
Fig. 21 Global drug discovery market, 2014 - 2025 (USD Million)
Fig. 22 Global agricultural biotechnology market, 2014 - 2025 (USD Million)
Fig. 23 Global other application market, 2014 - 2025 (USD Million)
Fig. 24 Global DNA & gene chip market: Product outlook key takeaways
Fig. 25 Global DNA & gene chip market: Product movement analysis
Fig. 26 Global consumables market, 2014 - 2025 (USD Million)
Fig. 27 Global instrumentation market, 2014 - 2025 (USD Million)
Fig. 28 Global DNA & gene chip market: End-use outlook key takeaways
Fig. 29 Global DNA & gene chip market: End-use movement analysis
Fig. 30 Global academic & government research institutes market, 2014 - 2025 (USD Million)
Fig. 31 Global hospitals & diagnostics centers market, 2014 - 2025 (USD Million)
Fig. 32 Global biotechnology & pharmaceutical companies market, 2014 - 2025 (USD Million)
Fig. 33 Global other end-use market, 2014 - 2025 (USD Million)
Fig. 34 Regional market place: Key takeaway
Fig. 35 DNA & gene chip regional outlook, 2017 & 2025
Fig. 36 North America DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 37 U.S. DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 38 Canada DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 39 Europe DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 40 Germany DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 41 U.K. DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 42 Asia Pacific DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 43 Japan DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 44 China DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 45 Latin America DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 46 Brazil DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 47 MEA DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 48 South Africa DNA & gene chip market, 2014 - 2025 (USD Million)
Fig. 49 Strategy framework
Fig. 50 Participant categorization
